Literature DB >> 2750489

The mononuclear cell infiltrate compared with survival in high-grade astrocytomas.

M L Rossi1, N R Jones, E Candy, J A Nicoll, J S Compton, J T Hughes, M M Esiri, T H Moss, F F Cruz-Sanchez, H B Coakham.   

Abstract

Frozen samples from 92 malignant astrocytomas were stained with a panel of monoclonal antibodies directed against macrophages and lymphocytes. A follow-up to death was available on 68 cases which form the basis of this study. Large numbers of macrophages were found in all cases; T lymphocytes, mostly of the CD8 phenotype were also seen in moderate numbers in 70% of cases. CD4-positive cells were present in small numbers in 32% and B cells were seen in only 8% of cases. Analysis of the survival showed no demonstrable correlation between the numbers of macrophages or CD4 lymphocytes and survival. The survival curves for parenchymal CD8 infiltration diverged after 9 months suggesting increased survival for those patients without such an infiltration but the difference failed to reach statistical significance (P = 0.37). No correlation between lymphocytic cuffing and survival was seen after studying all paraffin-embedded material. We conclude that there is no significant statistical correlation between survival and the various types of mononuclear cell infiltrating malignant astrocytomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2750489     DOI: 10.1007/bf00688208

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  35 in total

Review 1.  Immunobiology of human gliomas.

Authors:  D E Bullard; G Y Gillespie; M S Mahaley; D D Bigner
Journal:  Semin Oncol       Date:  1986-03       Impact factor: 4.929

2.  Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha.

Authors:  S J Leibovich; P J Polverini; H M Shepard; D M Wiseman; V Shively; N Nuseir
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

Review 3.  Applications of monoclonal antibodies in the diagnosis and treatment of primary brain tumors.

Authors:  D E Bullard; D D Bigner
Journal:  J Neurosurg       Date:  1985-07       Impact factor: 5.115

4.  Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

Authors:  M S Mahaley; W H Brooks; T L Roszman; D D Bigner; L Dudka; S Richardson
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

5.  Lymphocyte-mediated cytotoxicity against gliomas.

Authors:  S Rainbird; G Allwood; A Ridley
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

6.  Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

Authors:  L Palma; N Di Lorenzo; B Guidetti
Journal:  J Neurosurg       Date:  1978-12       Impact factor: 5.115

7.  Perivascular lymphocytic cuffing in astrocytomas.

Authors:  J Takeuchi; R O Barnard
Journal:  Acta Neuropathol       Date:  1976       Impact factor: 17.088

8.  Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies.

Authors:  F T Cordingley; A Bianchi; A V Hoffbrand; J E Reittie; H E Heslop; A Vyakarnam; M Turner; A Meager; M K Brenner
Journal:  Lancet       Date:  1988-04-30       Impact factor: 79.321

9.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

Authors:  J H Kehrl; A Miller; A S Fauci
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

10.  [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

Authors:  D Schiffer; G Croveri; C Pautasso
Journal:  Tumori       Date:  1974 May-Jun
View more
  20 in total

1.  CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

Authors:  Isaac Yang; Tarik Tihan; Seunggu J Han; Margaret R Wrensch; John Wiencke; Michael E Sughrue; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-08-19       Impact factor: 1.961

2.  Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma.

Authors:  T Morioka; T Baba; K L Black; W J Streit
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.

Authors:  Peter Hau; Leoni A Kunz-Schughart; Petra Rümmele; Füsun Arslan; Anett Dörfelt; Horst Koch; Annette Lohmeier; Birgit Hirschmann; Adolf Müller; Ulrich Bogdahn; Anja-Katrin Bosserhoff
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

4.  Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.

Authors:  Andrew M Donson; Diane K Birks; Stephanie A Schittone; Bette K Kleinschmidt-DeMasters; Derrick Y Sun; Molly F Hemenway; Michael H Handler; Allen E Waziri; Michael Wang; Nicholas K Foreman
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

5.  Dose and scanning delay using USPIO for central nervous system macrophage imaging.

Authors:  V Dousset; C Gomez; K G Petry; C Delalande; J M Caille
Journal:  MAGMA       Date:  1999-08       Impact factor: 2.310

Review 6.  Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme.

Authors:  Giannis Sokratous; Stavros Polyzoidis; Keyoumars Ashkan
Journal:  Hum Vaccin Immunother       Date:  2017-03-31       Impact factor: 3.452

7.  DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.

Authors:  Joost Dejaegher; Lien Solie; Zoé Hunin; Raf Sciot; David Capper; Christin Siewert; Sofie Van Cauter; Guido Wilms; Johan van Loon; Nadine Ectors; Steffen Fieuws; Stefan M Pfister; Stefaan W Van Gool; Steven De Vleeschouwer
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

8.  Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.

Authors:  Christine Lu-Emerson; Matija Snuderl; Nathaniel D Kirkpatrick; Jermaine Goveia; Christian Davidson; Yuhui Huang; Lars Riedemann; Jennie Taylor; Percy Ivy; Dan G Duda; Marek Ancukiewicz; Scott R Plotkin; Andrew S Chi; Elizabeth R Gerstner; April F Eichler; Jorg Dietrich; Anat O Stemmer-Rachamimov; Tracy T Batchelor; Rakesh K Jain
Journal:  Neuro Oncol       Date:  2013-07-04       Impact factor: 12.300

Review 9.  The role of microglia in central nervous system immunity and glioma immunology.

Authors:  Isaac Yang; Seunggu J Han; Gurvinder Kaur; Courtney Crane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-11-18       Impact factor: 1.961

10.  Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.

Authors:  W Caleb Rutledge; Jun Kong; Jingjing Gao; David A Gutman; Lee A D Cooper; Christina Appin; Yuna Park; Lisa Scarpace; Tom Mikkelsen; Mark L Cohen; Kenneth D Aldape; Roger E McLendon; Norman L Lehman; C Ryan Miller; Matthew J Schniederjan; Cameron W Brennan; Joel H Saltz; Carlos S Moreno; Daniel J Brat
Journal:  Clin Cancer Res       Date:  2013-07-17       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.